slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
780.000 KRW | -1,27% | -1,27% | +2,63% |
25/04 | Samsung Bioepis krijgt goedkeuring om auto-immuunbehandeling in Europa op de markt te brengen | MT |
25/04 | Samsung Biologics boekt meer winst en omzet in Q1 | MT |
Omzet 2024 * | 4.258 mld. 3,09 mld. 2,88 mld. | Omzet 2025 * | 4.962 mld. 3,6 mld. 3,36 mld. | Marktkapitalisatie | 55.516 mld. 40,3 mld. 37,58 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 985 mld. 715 mln. 667 mln. | Nettowinst (verlies) 2025 * | 1.195 mld. 868 mln. 809 mln. | EV/omzet 2024 * | 12,5 x |
Nettoliquiditeiten 2024 * | 2.085 mld. 1,51 mld. 1,41 mld. | Nettoliquiditeiten 2025 * | 3.166 mld. 2,3 mld. 2,14 mld. | EV/omzet 2025 * | 10,6 x |
K/w-verhouding 2024 * |
56,4
x | K/w-verhouding 2025 * |
47,7
x | Werknemers | 4.284 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 25,25% |
1 dag | -1,27% | ||
1 week | -1,27% | ||
Lopende maand | -6,14% | ||
1 maand | -7,14% | ||
3 maanden | -0,64% | ||
6 maanden | +7,88% | ||
Lopend jaar | +2,63% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Chongbo Rim
CEO | Chief Executive Officer | 62 | 01-01-18 |
Doyoung Heo
DFI | Director of Finance/CFO | - | - |
Tae-Han Kim
CHM | Chairman | 66 | 21-04-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chang-Woo Lee
BRD | Director/Board Member | 70 | - |
Tae-Han Kim
CHM | Chairman | 66 | 21-04-11 |
Seok-Woo Jung
BRD | Director/Board Member | 62 | - |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
4.63% | 2 M€ | -14,14% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 780.000 | -1,27% | 68 732 |
24-04-24 | 790.000 | -0,13% | 48 667 |
23-04-24 | 791.000 | -1,37% | 44 112 |
22-04-24 | 802.000 | +2,69% | 59 922 |
19-04-24 | 781.000 | -1,14% | 55 678 |
slotkoers Korea S.E., 25 april 2024
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,63% | 40,86 mld. | |
-4,59% | 87,31 mld. | |
-21,76% | 29,36 mld. | |
+58,56% | 24,49 mld. | |
-14,78% | 17,31 mld. | |
-18,49% | 11,62 mld. | |
-15,61% | 11,31 mld. | |
-44,02% | 11,26 mld. | |
+5,17% | 8,31 mld. | |
-7,49% | 7,9 mld. |